Skip to content

Pfft! PT-141 seems to be going up in smoke

August 31st, 2007

Dr Petra

You may have heard a lot about PT-141 over the last couple of years. Journalists have been endlessly promoting it as a forthcoming wonder drug that’s going to transform our sex lives.

Bremelanotide (PT-141) is a drug originally developed for erectile dysfunction but also being tested for treating women with sex problems. You’ll know it as the nasal spray sex drug – the one that’s spawned countless media features of ‘sex in a spray can’.

Well, it seems that the drug’s not doing quite so well as all the hype according to a feature in Forbes. It reports how shares have plummeted in King Pharmaceuticals and Palatin Technologies (who make PT-141). That’s because the US Food and Drug Administration (FDA) has ‘serious concerns’ about the design of their late stage trials of the drug. In particular they questioned the drug’s efficacy.

King and Palatin are going to delay the study because of worries about the drug including increases to blood pressure and side effects including nausea, vomiting and headaches.

There has been some media coverage of this case, mostly in the financial papers. However it’s been nowhere near the previous coverage the drug has had where it was given endless positive promotion in countless features.

If we lived in a world where the media was fair you’d now see the same magazines letting their readers know that the much promised ‘sex in a spray can’ drug may just give you a headache or make you throw up.

But we don’t live in a world like that so you can expect that journalists will continue to promote the drug, believe it exists already, or see it as the next best thing.

You know that’s not the case. There are serious limitations to this drug which is not currently being tested, and is unlikely to be made available for public use any time soon.

Here’s your chance to get involved in media monitoring – if you see any magazine or newspaper features mentioning PT-141 or ‘sex in a spray can’ or ‘sex nasal sprays’ let the journalist in question know they’re promoting a product that hasn’t yet passed the sniff test.

Comments are closed.